Literature DB >> 6157102

T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor.

Z Eshhar, R N Apte, I Löwy, Y Ben-Neriah, D Givol, E Mozes.   

Abstract

Thymus-derived lymphocytes (T cells) exert their regulatory effect (help or suppression) on the antibody production by B cells either by direct cell to cell interaction or by soluble mediators or factors. The low frequency of specific T cells, the heterogeneity of their responses and their relatively short life span have hampered the molecular characterization of the antigen recognition unit of T cells, and its structure is largely unknown. The lymphocyte hybridization technique, which has been found very useful for the production of B-cell hybridomas secreting specific monoclonal antibodies, has also been used for the generation of homogeneous and stable T-cell hybridomas with unlimited growth potential. So far the only specific effector function demonstrated in the established T hybridomas is the property to generate a factor(s) which suppresses antibody responses. We now describe the establishment of hybrid lines which exhibit characteristic T-cell markers. One of the hybridomas (denoted R-9) releases into the culture supernatant factor(s) with helper activity specific to the synthetic polypeptide (T,G)-A--L and bears surface determinants of the immunoglobulin heavy chain variable region (VH). Such hybrid cell lines are of great value for studies on the nature of the T-cell receptor.

Mesh:

Substances:

Year:  1980        PMID: 6157102     DOI: 10.1038/286270a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  13 in total

1.  Selection of BW 5147 subclones devoid of non-specific suppressive activity for use in cell hybridization.

Authors:  G Chaouat; M Liacopoulos-Briot; J Couderc; J Parlebas; Y Perrodon; O Briffaut; P Liacopoulos
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

Review 2.  Antigen-specific T-cell factors.

Authors:  M J Taussig
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

3.  Ia-antigen-T-cell interactions for a thymus-independent antigen composed of D amino acids.

Authors:  E Zisman; M Dayan; M Sela; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

4.  Serological analysis of idiotypic determinants on monoclonal antibodies specific to poly(Tyr,Glu)-poly(DLAla)--poly(Lys) and its ordered analogue (Tyr-Tyr-Glu-Glu)-poly(DLAla)--poly(Lys).

Authors:  B Parhami-Seren; Z Eshhar; E Mozes
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

5.  T-cell hybridoma specific for a cytochrome c peptide: specific antigen binding and interleukin 2 production.

Authors:  S Carel; C Bron; G Corradin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  Structural analysis of antigen-specific Ia-bearing regulatory T-cell factors: gel electrophoretic analysis of the antigen-specific augmenting T -cell factor.

Authors:  S Miyatani; K Hiramatsu; P B Nakajima; F L Owen; T Tada
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

7.  Anti-VH antibodies interfere with antigen binding by human T lymphocytes.

Authors:  T Lea; T E Michaelsen
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

8.  Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro.

Authors:  Y Kaufmann; G Berke; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

9.  H-2-restricted helper factor secreted by clone hybridoma cells.

Authors:  P Lonai; J Puri; S Bitton; Y Ben-Neriah; D Givol; G J Hämmerling
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Analysis of T cell hybridomas. II. Comparisons among three distinct types of monoclonal suppressor factors.

Authors:  K Okuda; M Minami; M Furusawa; M E Dorf
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.